1. Home
  2. NRSN vs JZXN Comparison

NRSN vs JZXN Comparison

Compare NRSN & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • JZXN
  • Stock Information
  • Founded
  • NRSN 2017
  • JZXN 2017
  • Country
  • NRSN Israel
  • JZXN China
  • Employees
  • NRSN N/A
  • JZXN N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • JZXN Retail-Auto Dealers and Gas Stations
  • Sector
  • NRSN Health Care
  • JZXN Consumer Discretionary
  • Exchange
  • NRSN Nasdaq
  • JZXN Nasdaq
  • Market Cap
  • NRSN 17.8M
  • JZXN 14.6M
  • IPO Year
  • NRSN 2021
  • JZXN 2021
  • Fundamental
  • Price
  • NRSN $1.09
  • JZXN $1.57
  • Analyst Decision
  • NRSN Hold
  • JZXN
  • Analyst Count
  • NRSN 1
  • JZXN 0
  • Target Price
  • NRSN N/A
  • JZXN N/A
  • AVG Volume (30 Days)
  • NRSN 374.5K
  • JZXN 160.2K
  • Earning Date
  • NRSN 12-18-2024
  • JZXN 09-09-2024
  • Dividend Yield
  • NRSN N/A
  • JZXN N/A
  • EPS Growth
  • NRSN N/A
  • JZXN N/A
  • EPS
  • NRSN N/A
  • JZXN N/A
  • Revenue
  • NRSN N/A
  • JZXN $7,597,423.00
  • Revenue This Year
  • NRSN N/A
  • JZXN N/A
  • Revenue Next Year
  • NRSN N/A
  • JZXN N/A
  • P/E Ratio
  • NRSN N/A
  • JZXN N/A
  • Revenue Growth
  • NRSN N/A
  • JZXN 81.94
  • 52 Week Low
  • NRSN $0.51
  • JZXN $1.00
  • 52 Week High
  • NRSN $2.33
  • JZXN $67.60
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 47.35
  • JZXN 53.86
  • Support Level
  • NRSN $1.01
  • JZXN $1.41
  • Resistance Level
  • NRSN $1.13
  • JZXN $1.63
  • Average True Range (ATR)
  • NRSN 0.09
  • JZXN 0.16
  • MACD
  • NRSN -0.01
  • JZXN 0.01
  • Stochastic Oscillator
  • NRSN 27.27
  • JZXN 54.00

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About JZXN Jiuzi Holdings Inc.

Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its business segments are sales of NEVs and Franchisees services. The company generates a majority of its revenue from the NEVs segment. Geographically, the firm operates in China.

Share on Social Networks: